News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Intuitive Surgical (ISRG) has filed a $1.77 billion shelf registration for an employee stock ownership plan, providing flexibility for future share issuance to employees. This move could impact the company's capital structure and ownership mix, especially given the stock's recent decline of 37.7% year-to-date. …
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%Intuitive Surgical Inc (ISRG) reported strong second-quarter 2026 results, with revenue reaching $2.89 billion and diluted EPS at $2.29, both showing significant year-over-year increases. The growth was driven by increased system placements, recurring revenue, and higher procedure volumes, including a 15% rise in da …
NZS Capital, LLC, an investment management company, released its "NZS Growth Equity Strategy" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Equity markets delivered a strong performance in the second quarter of 2026, driven by demand for AI infrastructure, …
Intuitive Surgical (ISRG) stock has fallen significantly this year, reaching multi-year lows despite strong financial performance, including a 19% revenue increase in its second quarter. The decline is attributed to factors like the expiration of ACA enhanced premiums and rising GLP-1 weight loss drug …
Certain options of SurgePays, Inc. are under a lock-up agreement set to expire on July 21, 2026. This agreement, lasting 181 days from January 21, 2026, restricts executive officers, directors, and significant shareholders from selling or hedging their common stock or equivalents. The lock-up …
The robotic-surgery name is drawing active-mover attention after a steep weekly reset in a large-cap healthcare stock.
Intuitive Surgical, Inc. (ISRG) published its 2026 Q2 earnings call presentation. The company reported EPS of $2.80, beating estimates by $0.30, and revenue of $2.89 billion, exceeding expectations by $67.30 million with a year-over-year increase of 18.54%. This article by SA Transcripts provides access …
Sharemaestro market context Price below Trend Line 52 weeks -23.4%Intuitive Surgical reported strong revenue and earnings, yet its stock dropped significantly due to concerns about slowing U.S. da Vinci procedure growth and an upcoming extended-use program that will lower costs for hospitals. While capital sales of its new da Vinci 5 system remain …
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. That's because, these stocks usually carry above-average risk and volatility. In …
STAAR Surgical announced significantly raised revenue guidance for Q2 2026, expecting net sales to exceed US$90 million compared to US$44.3 million in Q2 2025. This surge, potentially driven by the FDA's expanded age indication for EVO ICLs, suggests strong business momentum and could reshape …
A downtrend has been apparent in Intuitive Surgical, Inc. (ISRG) lately with too much selling pressure. The stock has declined 15.1% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in …
Intuitive Surgical, Inc. (ISRG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this company …
This article analyzes potential investment opportunities in Intuitive Surgical, Inc. (NASDAQ:ISRG). It likely discusses factors such as the company's valuation, market position, and future growth prospects to determine if its stock currently presents an attractive entry point for investors.
Key Points Intuitive Surgical posted strong sales and profit gains in the second quarter. But management issued a tepid forecast for the rest of 2026.10 stocks we like better than Intuitive Surgical › Shares of Intuitive Surgical (NASDAQ: ISRG) fell this past week on …
Sharemaestro market context Price below Trend Line 52 weeks -23.4%Intuitive Surgical (ISRG) reported strong Q2 2026 earnings with a 19% revenue increase and higher net income, yet its stock fell 10% after hours. This drop was primarily due to the company not raising its full-year guidance for da Vinci procedures, signaling slower growth, …
STAAR Surgical's stock, despite a recent rebound, presents a mixed valuation picture. While the Discounted Cash Flow (DCF) model suggests it's 11.9% undervalued, traditional market multiples like the P/S ratio indicate it might be overvalued compared to its industry and fair ratio. The article …
STAAR Surgical (STAA) stock is down over 9% and is headed for its largest single-day percentage decrease since February 2025. This significant drop follows a period of notable gains, including a recent 2.41% increase on Friday. The article highlights key financial metrics including its …
Intuitive Surgical (ISRG) shares fell approximately 9% after the company reported stronger-than-expected second-quarter results but reaffirmed its full-year guidance for da Vinci procedure growth and gross margin. Investors reacted negatively to the unchanged outlook, especially regarding the expected impact of tariffs on margins, despite …
Intuitive Surgical (ISRG) stock fell despite beating Q2 2026 financial expectations, as concerns arose over U.S. growth in its da Vinci robotic surgical systems. Analysts cited potential headwinds from the Affordable Care Act (ACA) and increased uncertainty leading to a more conservative management outlook. …
Intuitive Surgical (ISRG) stock is experiencing a significant downturn after its full-year guidance triggered multiple Wall Street price target cuts, despite beating Q2 earnings estimates. Analysts are concerned about the deceleration in U.S. procedure growth, with management revising da Vinci procedure growth expectations downwards. …
Shares of STAAR Surgical, Globus Medical, Integer Holdings, and Enovis all traded down after Intuitive Surgical warned that changes to insurance plans could slow U.S. procedure growth, raising fears of a sector-wide slowdown in the medical devices and supplies industry. The news suggests that …
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%The medical device sector, particularly companies like STAAR Surgical, is experiencing declines due to investor concerns over insurance changes potentially slowing U.S. procedure growth, highlighted by Intuitive Surgical's warning. STAAR Surgical's stock dropped 10.1%, and despite some positive analyst sentiment and strong Q1 earnings, …
This article provides financial information for SurgePays Inc (FWB:9B90) on the Frankfurt Stock Exchange. It specifically mentions the "Price to book forward" metric for the company. The content appears to be a stub or a placeholder, lacking actual financial data beyond the mention of …
Intuitive Surgical (ISRG) stock dropped significantly after the company reported moderated U.S. procedure growth, particularly in deferrable procedures and due to GLP-1 usage affecting bariatric cases. The company also faces challenges from increased domestic competition and policy-driven pricing pressure in China. Analysts subsequently cut …
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%STAAR Surgical (NASDAQ: STAA) stock experienced a decline despite reporting strong preliminary Q2 net sales exceeding $90 million, driven by a rebound in China and solid momentum in the Americas. However, the company faced headwinds in the EMEA region due to geopolitical tensions in …
Stifel has lowered its price target for Intuitive Surgical (NASDAQ:ISRG) to $550 from $670, while maintaining a Buy rating. This reduced target comes despite the company exceeding Q2 2026 revenue and earnings expectations, due to management's commentary indicating slower U.S. procedure and installed base …
Intuitive Surgical's stock has declined due to concerns that changes in the Affordable Care Act (ACA) and the increasing use of GLP-1 weight-loss drugs could negatively impact the company's growth. The article highlights how these external factors are influencing the medical device sector, specifically …
Intuitive Surgical Inc. (NASDAQ:ISRG) reported strong Q2 2026 results, surpassing analyst expectations for both earnings per share and revenue. However, the company's shares tumbled 10.9% due to a weaker-than-expected full-year 2026 da Vinci procedure growth outlook of 13.5% to 15.5%. Despite the solid quarterly …
Several major stocks, including Intuitive Surgical, Netflix, and Applied Materials, experienced significant declines in pre-market trading on Friday. Intuitive Surgical fell after reporting mixed Q2 results despite beating earnings estimates, while Netflix dropped due to weak Q3 guidance. Other companies like Regenxbio and STAAR …
STAAR Surgical’s Q2 net sales more than doubled year-over-year to $90 million, slightly missing analyst expectations for $90.26 million. This growth was primarily driven by strong performance in China and the broader Asia-Pacific region, alongside double-digit gains in the Americas. However, sales in EMEA …
Staar Surgical (Nasdaq: STAA) saw its shares fall 8.4% in after-hours trading following the release of its preliminary Q2 sales. While the company expects revenue to exceed $90 million, a 123% increase year-over-year, specific sales in the EMEA region experienced a low single-digit decline …
Intuitive Surgical reported stronger-than-expected Q2 2026 results, surpassing analyst estimates for both profit and revenue, but its shares dropped significantly after hours. The decline was attributed to investor concerns over slowing U.S. procedure growth and a cautious outlook, despite the company maintaining its full-year …
Sharemaestro market context Price below Trend Line 52 weeks -19.5%Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.